Globus Medical Inc (GMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 526,156 | 784,438 | 467,292 | 150,466 | 193,069 |
| Marketable Securities | 31,087 | 105,619 | 50,497 | 295,592 | 250,378 |
| Receivables | 743,665 | 578,330 | 504,870 | 217,308 | 165,651 |
| Inventories | 759,277 | 659,233 | 848,135 | 298,981 | 237,001 |
| TOTAL | $2,125,611 | $2,177,260 | $1,915,374 | $983,344 | $864,516 |
| Non-Current Assets | |||||
| PPE Net | 564,452 | 561,909 | 586,932 | 243,729 | 221,076 |
| Investments And Advances | 71,819 | 66,134 | 75,428 | 495,852 | 562,475 |
| Intangibles | 2,180,097 | 2,227,504 | 2,359,143 | 261,045 | 248,368 |
| Other Non-Current Assets | 360,782 | 218,943 | 149,206 | 92,156 | 60,828 |
| TOTAL | $3,177,150 | $3,074,490 | $3,170,709 | $1,092,782 | $1,092,747 |
| Total Assets | $5,302,761 | $5,251,750 | $5,086,083 | $2,076,126 | $1,957,263 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 443,351 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 98,852 | 75,118 | 56,671 | 36,101 | 24,155 |
| Accrued Expenses | 333,586 | 260,591 | 240,460 | 92,169 | 91,168 |
| Other current liabilities | 19,513 | 33,739 | 61,035 | 13,308 | 11,770 |
| TOTAL | $498,499 | $855,913 | $392,347 | $159,204 | $140,164 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 417,400 | 0 | N/A |
| Deferred Revenues | 27,655 | 22,140 | 18,369 | 14,100 | 12,025 |
| Other Non-Current Liabilities | 207,256 | 194,615 | 193,956 | 68,770 | 71,397 |
| TOTAL | $231,012 | $218,504 | $695,777 | $70,549 | $75,711 |
| Total Liabilities | $729,511 | $1,074,417 | $1,088,124 | $229,753 | $215,875 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 135,253 | 137,542 | 135,372 | 100,303 | 101,558 |
| Common Shares | 135 | 137 | 136 | 100 | 101 |
| Retained earnings | 1,387,957 | 1,152,813 | 1,137,266 | 1,239,951 | 1,194,272 |
| Other shareholders' equity | 15,346 | -6,861 | -10,192 | -24,630 | -6,772 |
| TOTAL | $4,573,250 | $4,177,333 | $3,997,959 | $1,846,373 | $1,741,388 |
| Total Liabilities And Equity | $5,302,761 | $5,251,750 | $5,086,083 | $2,076,126 | $1,957,263 |